Phase IV Clinical Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.

PHASE4CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

May 15, 2023

Study Completion Date

May 15, 2023

Conditions

Dry Eye

Interventions

DRUG

Sodium hyaluronate 0.1%/chondroitin sulfate 0.18%

Application of one drop of Humylub Ofteno® PF (Sodium hyaluronate 0.1%/chondroitin sulfate 0.18%) QID in both eyes (OU) during 30 days.

DRUG

Sodium hyaluronate 0.15%

Application of one drop of Hyabak® PF (Sodium hyaluronate 0.15%) QID in OU during 30 days.

DRUG

Sodium hyaluronate 0.4%

Application of one drop of Lagricel Ofteno® PF (Sodium Hyaluronate 0.4%) QID in OU during 30 days.

Trial Locations (1)

Unidad Clínica de Bioequivalencia, S. de R.L. de C.V., Guadalajara

All Listed Sponsors

lead

Laboratorios Sophia S.A de C.V.

INDUSTRY